Journal of the Pancreas Open Access

  • ISSN: 1590-8577
  • Journal h-index: 79
  • Journal CiteScore: 29.12
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +447482874092

Opinion Article - (2021) Volume 22, Issue 6

Why do we need to be focused on pancreatic cancer?

Athiba Saha*

Deparment of Oncology, Univeristy of Mumbai, India

Corresponding Author:
Athiba Saha
Deparment of Oncology
University of Mumbai
Mumbai, India
Tel: 9846466893
E-mail: [email protected]

Received Date: Jun 09th, 2021; Accepted Date: Jun 23rd 2021

Visit for more related articles at Journal of the Pancreas

Pancreatic cancer has come to be Third leading cause of death from sicknesses in India and Europe. The incidence of pancreatic cancer is growing day by day. High-quality efforts have been devoted to basic and clinical studies in pancreatic cancers. However, the outcome of pancreatic cancer has been minimally stepped forward over the past thirty years. This type of profound sadness tells us that we need to spend greater efforts and be greater centered in this sickness. There had been no scientific journal this is totally centered on the malignant Sicknesses of the pancreas. It is critical to have a media to swiftly disseminate research news and reports within the communities of pancreatic cancer researchers and feature a venue to speak about the control techniques for pancreatic most cancers among clinicians. This is why we are launching Journal of Pancreas.

In the past decades, we recognize that we have to manipulate the care for pancreatic cancer in a multidisciplinary way because we've very restricted alternatives for pancreatic cancer patients in each individual scientific strong point. Even for those resectable cancer, the five-12 months survival following the surgical resection is best round 15%. We hence apprehend that none of pancreatic cancer sufferers were clearly identified at early degree. One of the keys for curing pancreatic cancer is to diagnose at an early stage or diagnose it at its premalignant stage which is understood to be in truly curable. We also apprehend that focused on neoplastic cells of pancreatic cancer is often not a success due to the fact common genetic changes in pancreatic most cancers aren't actionable. The stroma of pancreatic cancer has drawn a great interest, which has shifted the paradigm of healing development for pancreatic most cancers. Despite the fact that, the complexity of the tumor microenvironment of pancreatic cancer has often led to many arguable study’s findings, suggesting that we want to create no barrier however an extra speedy venue for the booklet of those controversial findings. We need to make the communities of studies and improvement absolutely aware about the complexity of pancreatic cancer and consequently will not make the identical detours in the improvement of recent therapeutics for this challenging diseases.

We can make this journal for all researchers in the area of pancreatic cancer, pancreas and for all health care providers who control the pancreatic cancer in patients. The journal will cover subjects from all aspects of pancreas, tumors inclusive of basic biology and immunology, epidemiology, prevention, analysis, treatment, and supportive care. We will use this journal to convey collectively all scientists and clinicians beneath the same ceiling to speak about how we will higher recognize and deal with pancreatic cancer. The principle goal of the journal is to make our clinicians incorporate the knowledge from fundamental technology studies into their routine control and medical investigation of pancreatic cancer and also to inspire our scientists to have the translational intuitiveness in their epidemiology and laboratory researches.